Log In
    News

    QuickChek – May 14, 2021

    5/14/2021
    Markets
    0 min read
    GEVO up 20% in midday trading

    The company reported first quarter 2021 financial results yesterday

    Read today’s GEVO report from Noble Analyst Poe Fratt



    Harte Hanks Reports First Quarter 2021 Financial Results

    Harte Hanks announced financial results for the first quarter ended March 31, 2021

    Research, News & Market Data on Harte Hanks



    Energy Fuels Announces Q1-2021 Results

    Energy Fuels reported its financial results for the quarter ended March 31, 2021

    Research, News & Market Data on Energy Fuels

    Watch recent presentation from Energy Fuels



    Ayala Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business Update

    Ayala Pharmaceuticals reported financial results for the first quarter ended March 31, 2021 and highlighted recent progress and upcoming milestones for its pipeline programs

    Research, News & Market Data on Ayala

    Watch recent presentation from Ayala

    Stay up to date. Follow us:

    Share
    Related News
    ‌
    Celsius Acquires Alani Nutrition in $1.8 Billion Deal
    2/21/2025
    Food and Services

    Celsius Acquires Alani Nutrition in $1.8 Billion Deal

    Celsius Holdings has announced plans to acquire Alani Nutrition in a landmark $1.8 billion deal, marking a major consolidation in the U.S. energy drink market. The agreement, expected to be...
    3 min read
    ‌
    Release – GDEV Declares One-Time, Nonrecurring Special Cash Dividend of $3.31 Per Share
    2/21/2025
    Media and Entertainment

    Release – GDEV Declares One-Time, Nonrecurring Special Cash Dividend of $3.31 Per Share

    GDEV Inc. (Nasdaq: GDEV), an international gaming and entertainment company (“GDEV” or the “Company”), today announced that its Board of Directors has authorized and approved a one-time, nonrecurring special cash...
    4 min read
    ‌
    Release – Ocugen to Host Conference Call on Wednesday, March 5, 2025 at 8:30 A.M. ET to Discuss Business Updates and Fourth Quarter and Full Year 2024 Financial Results
    2/21/2025
    Health

    Release – Ocugen to Host Conference Call on Wednesday, March 5, 2025 at 8:30 A.M. ET to Discuss Business Updates and Fourth Quarter and Full Year 2024 Financial Results

    Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, today announced that it will...
    3 min read
    ‌
    Unicycive Therapeutics (UNCY) – OLC Shows Synergy With Alternative Potassium Binder
    2/21/2025
    Healthcare

    Unicycive Therapeutics (UNCY) – OLC Shows Synergy With Alternative Potassium Binder

    Pre-Clinical Study Shows Synergy With Tenapanor. Unicycive Therapeutics announced the results of an animal model study that tested its phosphate binder, OLC, or oxylanthanum carbonate, and tenapanor, a phosphate-control drug that...
    2 min read

    Inbox Intel from Channelchek.

    Informed investors make more money. And it’s all about timing. Get it when it happens.

    By clicking submit you are agreeing to the Terms of Use and Privacy Policy
    Log In